The pharmacological pathways of GnRH mediating the inhibition of mammary tumours: Implications in humans and domestic animals

Current Medicinal Chemistry

Volumn 19, Issue 7, 2012, Pages 982-991

  Rizzo, A ^a   Spedicato, M ^a   Mutinati, M ^a   Minoia, G ^a   Patruno, R ^b   Ranieri, G ^b   Sciorsci, R L ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Angiogenesis; Domestic animals; Fibrosis; GnRH analogues; GnRH receptor; Growth factors; Kisspeptin; Mammary tumours; Metastasis; VEGF

Indexed keywords

GONADORELIN; GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BREAST TUMOR; DOMESTIC ANIMAL; GONADORELIN RELEASE; HORMONE SYNTHESIS; HUMAN; METASTASIS; NEOPLASM; NONHUMAN; REVIEW;

EID: 84858234699     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712799320745     Document Type: Review

References (187)

1. Schneider, F.; Tomek, W.; Gründker, C. Gonadotropin-releasing hormone (GnRH) and its natural analogues: a review. Theriogenology, 2006, 66, 691-709. (Pubitemid 44188859)
2. Matsuo, H.; Baba, Y.; Nair, R.M.G.; Akimura, A.; Schally, A.V. Structure of the porcine LH and FSH releasing hormone. I. The proposed amino acid sequence. Biochem. Biophys. Res. Commun., 1971, 43, 1334-1339.
3. Amoss, M.; Burgus, R.; Blackwell, R.; Vale, W.; Fellows, R.; Guillermann, R. Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone-releasing factor. Biochem. Biophys. Res. Commun., 1971, 44, 205-210.
4. Millar, R.P. GnRH and GnRH receptors. Anim. Reprod. Sci., 2005, 88, 5-28.
5. Pawson, A.J.; McNeilly, A.S. The pituitary effects of GnRH. Anim. Reprod. Sci., 2005, 88, 75-94. (Pubitemid 41225344)
6. Millar, R.P. GnRH II and type II GnRH receptors. Trends Endocrinol. Metab., 2002, 14, 35-43. (Pubitemid 36733930)
7. Maiti, K.; Li, J.H.; Wang, A.F.; Acharjee, S.; Kim, W.P.; Im, W.B. GnRH-II analogs for selective activation and inhibition of non mammalian and type 2 mammalian GnRh receptors. Mol. Cells, 2003, 16, 173-179.
8. White, R.B.; Eisen, J.A.; Kasten, T.L.; Fernald, R.D. Second gene for gonadotropin releasing hormone in humans. Proc. Natl. Acad. Sci. USA, 1998, 95, 305-309. (Pubitemid 28103949)
9. Bono, A.V.; Salvadore, M.; Celato, N. Gonadotropin-releasing hormone receptors in prostate tissue. Anal. Quant. Cytol. Histol., 2002, 24, 221-227.
10. Whitelaw, P.F.; Eidne, K.A.; Sellar, R.; Smyth, C.D.; Hillier, S.G. Gonadotropin-releasing hormone receptor ribonucleic acid expression in rat ovary. Endocrinology, 1995, 136, 172-179.
11. Ramakrishnappa, N.; Rajamahendran, R.; Lin, Y.M.; Leung, P.C.K. GnRH in non hypothalamic tissues. Anim. Reprod. Sci., 2005, 88, 95-113.
12. Raga, F.; Casan, E.M.; Wen, Y.; Huang, H.; Polan, M.L. Independent regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1), TIMP-3 in human endometrial stromal cells by GnRH: implication in early human implantation. J. Clin. Endocrinol. Metab., 1999, 84, 636-642. (Pubitemid 29075698)
13. Chou, C.S.; MacCalman, C.D.; Leung, P.C. Differential effects of gonadotropin releasing hormone I and II on the urokinase-type plasminogen activator/plasminogen activator inhibitor system in human decidual stromal cells in vitro. J. Clin. Endocrinol. Metab., 2003, 88, 3806-3815. (Pubitemid 37034532)
14. Kottler, M.L.; Starzee, A.; Carre, M.C.; Lagarde, J.P.; Martin, A.; Counis, R. The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer. Int. J. Cancer, 1997, 71, 595-599. (Pubitemid 27239369)
15. Dolan, S.; Evans, N.P.; Richter, T.A.; Nolan, A.M. Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor in sheep spinal cord. Neurosci. Lett., 2003, 346, 120-122. (Pubitemid 36792208)
16. Miyamoto, K.; Hasegawa, Y.; Nomura, M.; Igarashi, M.; Kanagawa, K.; Matsuo, H. Identification of a second gonadotropin releasing hormone in chicken hypothalamus: evidence that gonadotropin secretion is probably controlled by two distinct gonadotropin-releasing hormones in avian species. Proc. Natl. Acad. Sci. U.S.A., 1984, 81, 3874-3878).
17. Millar, R.P.; Lowe, S.; Conklin, D.; Pawson, A.; Maudsley, S.; Troskie, B.; Ott, T.; Millar, M.; Lincoln, G.; Sellar, R.; Faurholm, B.; Scobie, G.; Kuestner, R.; Terasawa, E.; Katz, A. A novel mammalian receptor for the evolutionarily conserved type II GnRH. Proc. Natl. Acad. Sci. U.S.A., 2001, 98, 9636-9641. (Pubitemid 32769355)
18. Yoshioka, K.; Suzuki, C.; Arai, S.; Iwamura, S.; Hirose, H. Gonadotropin-releasing hormone in third ventricular cerebrospinal fluid of the heifer during the estrous cycle. Biol. Reprod., 2001, 64, 563-570. (Pubitemid 32109745)
19. Caraty, A.; Skinner, D.C. Gonadotropin-Releasing Hormone in third ventricular cerebrospinal fluid: endogenous distribution and exogenous uptake. Endocrinology, 2008, 149(10), 5227-5234.
20. Gorbman, A.; Sower, S.A. Evolution of the role of GnRH in animal (Metazoan) biology. Gen. Comp. Endocrinol., 2003, 134, 207-213. (Pubitemid 37443475)
21. Millar, R.P.; Lu, Z.-L.; Pawson, A.J.; Flanagan, C.A.; Morgan, K., Maudsley, S. Gonadotropin-releasing hormone receptors. Endocrinol. Rev., 2004, 25, 235-275. (Pubitemid 38501395)
22. Sealfon, S.C.; Weinstein, H.; Millar, R.P. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr. Rev., 2007, 13(2), 180-205.
23. Clarke, I.J.; Pompolo, S. Synthesis and secretion of GnRH. Anim. Reprod. Sci., 2005, 88, 29-55. (Pubitemid 41225342)
24. Sherwood, N.M.; Lovejoy, D.A.; Coe, J.R. Origin of mammalian gonadotropin releasing hormone. Endocr. Rev., 1993, 14, 241-254.
25. Tobet, S.A.; Bless, E.P.; Schwarting, G.A. Developmental aspect of the gonadotropin-releasing hormone system. Mol. Cell. Endocrinol., 2001, 185, 173-184. (Pubitemid 33103966)
26. Bless, E.P.; Walker, H.J.; Yu, K.W.; Knoll, J.G.; Moenter, S.M.; Schwarting G.A.; Tobet S.A. Live view of gonadotropin releasing hormone containing neuron migration. Endocrinology, 2005, 146, 463-468. (Pubitemid 40051772)
27. Wirsig Wiechmann, C.R. Function of gonadotropin re leasing hormone in olfaction. Keio J. Med., 2001, 50, 81-85.
28. Smith, M.J.; Jennes, L. Neural signals that regulate GnRH neurons directly during the oestrous cycle. Reproduction, 2001, 122, 1-10. (Pubitemid 32677143)
29. Viezarra, J.A.; Wettermann, R.P.; Braden, D.T.; Turzillo, A.M.; Nett, T.M. Effect of gonadotropin releasing hormone (GnRH) pulse frequency on serum and pituitary concentrations of luteinizing hormone and follicle stimulating hormone, GnRH receptors, and messenger ribonucleic acid for gonadotropin subunits in cows. Endocrinology, 1997, 138, 594-601. (Pubitemid 27110907)
30. D'Occhio, M.J.; Fordyce, G.; Whyte, T.R.; Jubb, T.F.; Fitzpatrick, L.A.; Cooper, N.J.; Aspden, W.J.; Bolam, M.J.; Trigg, T.E. Use of GnRH agonist implants for long term suppression of fertility in extensively managed heifers and cows. Anim. Reprod. Sci., 2002, 74, 151-162. (Pubitemid 35343673)
31. Piva, F.; Zanisi, M.; Motta, M.; Martini, L. "Ultrashort" control of hypothalamic hormones secretion: a history. J. Endocrinol. Invest., 2004, 27(6), 68-72.
32. Herbison, A.E. Noradrenergic regulation of cyclic GnRH secretion. Rev. Reprod., 1997, 2, 1-16.
33. Brann, D.W.; Mahesh, V.B. Excitatory amino acids: evidence for a role in the control of reproduction and anterior pituitary hormone secretion. Endocr. Rev., 1997, 18, 678-700. (Pubitemid 27435540)
34. Sahu, A.; Kalra, S.P. Absence of increased neuropeptide Y neuronal activity before and during the LH surge may underlie the attenuated preovulatory LH surge in middle-aged rats. Endocrinology, 1998, 139, 696-702.
35. Kalra, S.P. Mandatory neuropeptide-steroid signaling for the preovulatory luteinizing hormone-releasing hormone discharge. Endocr. Rev., 1993, 14, 507-537.
36. Sciorsci, R.L.; Bianchi, P.; Minoia, P. High levels of endorphin and related pathologies of veterinary concern. A review. Immunopharmacol. Immunotoxicol., 2000, 22(4), 575-626.
37. Mitchell, V.; Prevot, V.; Jennes, L.; Aubert, J.P.; Croix, D.; Beauvillain, J.C. Presence of mu and kappa opioid receptors in galanin but not in GnRH neurons in the female rat. Neuroreport, 1997, 8, 3167-3172.
38. Sannella, M.I.; Petersen, S.L. Dual label in situ hybridization studies provide evidence that luteinizing hormone-releasing hormone neurons do not synthesize messenger ribonucleic acid for mu, kappa, or delta opiate receptors. Endocrinology, 1997, 138, 1667-1672. (Pubitemid 27137120)
39. Lee, J.H.; Miele, M.E.; Hicks, D.J.; Phillips, K.K.; Trent, J.M.; Weissman, B.E.; Welck, D.R. KiSS-1, a novel malignant melanoma metastais-suppressor gene. J. Natl. Cancer Inst., 1996, 88, 1731-1737.
40. Muir, A.I.; Chamberlain, L.; Elshourbagy, N.A.; Michalovic, D.; Moore, D.J.; Calamari, A.; Szekeres, P.G.; Sarau, H.M.; Chambers, J.K.; Murdock, P. AXOR12, a novel human G-protein coupled receptor, activated by the peptide KiSS-1. J. Biol. Chem., 2001, 276, 28969-28975.
41. Ohtaki, T.; Shintani, Y.; Honda, S.; Matsumoto, H.; Hori, A.; Kanehashi, K.; Terao, Y.; Kumano, S.; Takatsu, Y.; Masuda, Y. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature, 2001, 411, 613-617. (Pubitemid 32531412)
42. Kotani, M.; Detheux, M.; Vandenbogaerde, A.; Communi, D.; Vanderwinden, J.M.; Le Poul, E.; Brezillon, S.; Tyldesley, R.; Suarez- Huerta, N.; Vandeput, F. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J. Biol. Chem., 2001, 276, 34631-34636.
43. de Roux, N.; Genin, E.; Carel, J.C.; Matsuda, F.; Chaussain, J.L.; Milgrom, E. Hypogonadotropic hypogonadism due to loss of function of the KiSS-1 derived peptide receptor GPR54. Proc. Natl. acad. Sci. USA, 2003, 100, 10972-10976. (Pubitemid 37140137)
44. Seminara, S.B.; Messager, S.; Chatzidaki, E.E.; Thresher, R.R.; Acierno, J.S. Jr.; Shagoury, J.K.; Bo-Abbas, Y.; Kuohung, W.; Schwinof, K.M.; Hendrick,A.G.; Zahn, D.; Dixon, J., Kaiser, U.B.; Slaugenhaupt, S.A.; Gusella, J.F.; O'Rahilly, S.; Carlton, M.B.; Crowley, W.F. Jr.; Aparicio, S.A.; Colledge, W.H. The GPR54 gene as a regulator of puberty. N. Engl. J. Med., 2003, 349, 1614-1627. (Pubitemid 37303886)
45. Hameed, S.; Jayasena, C.N.; Dhillo, W.S. Kisspeptin and fertility. J. Endocrinol., 2011, 208, 97-105.
46. Messager, S.; Chatzidaki, E.E.; Ma, D.; Hendrick, A.G.; Zahn, D.; Dixon, J.; Thresher, R.R.; Malinge, I.; Lomet, D.; Carlton, M.B.; Colledge, W.H.; Caraty, A.; Aparicio, S.A. Kisspeptin directly stimulates gonadotropin-releasing hormone secretion via G protein-coupled receptor 54. Proc. Natl. Acad. Sci. USA, 2005, 102, 1761-1766. (Pubitemid 40209241)
47. Hashizume, T.; Saito, H.; Sawada, T.; Yaegashi, T.; Ahmed Ezzat, A.; Sawai, K.; Yamashita, T. Characteristics of stimulation of gonadotropin secretion by kisspeptin-10 in female goats. Anim. Reprod., 2010, Sci. 118, 37-41.
48. Kadokawa, H.; Matsui, M.; Hayashi, K.; Matsunaga, N.; Kawashima, C.; Shimizu, T.; Kida, K.; Miyamoto, A. Peripheral administration of kisspeptin- 10 increases plasma concentrations of GH as well as LH in prepubertal Holstein heifers J. Endocrinol., 2008, 196, 331-334. (Pubitemid 351298518)
49. Ezzat Ahmed, A.; Saito, H.; Sawada, T.; Yaegashi, T.; Yamashita, T.; Hirata, T-I.; Sawai, K.; Hashizume, T. Characteristics of the stimulatory effect of kisspeptin-10 on the secretion of luteinizing hormone, follicle-stimulating hormone and growth hormone in prepubertal male and female cattle. J. Reprod. Develop., 2009, 55, 650-654.
50. Gottsch, M.L.; Cunningham, M.J.; Smith, J.T.; Popa, S.M.; Acohido, B.V.; Crowley, W.F.; Seminara, S.; Clifton, D.K.; Steiner, R.A. A role for kisspeptins in the regulation of gonadotropin secretion in mouse. Endocrinology, 2004, 145, 4073-4077. (Pubitemid 39120554)
51. Irwig, M.S.; Fraley, G.S.; Smith, J.T.; Acohido, B.V.; Popa, S.M.; Cunningham, M.J.; Gottsch, M.L.; Clifton, D.K.; Steiner, R.A. Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology, 2004, 80, 264-272. (Pubitemid 40187012)
52. Navarro, V.M.; Castellano, J.M.; Fernandez-Fernandez, R.; Tovar, S.; Roa, J.; Mayen, A.; Nogueiras, R.; Vazquez, M.J.; Barreiro, M.L.; Magni, P. Characterization of the potent LH releasing activity of KiSS-1 peptide, the endogenous ligand of GPR54. Endocrinology, 2005, 146, 156-163. (Pubitemid 40051735)
53. Shahab, M.; Mastronardi, C.; Seminara, S.B.; Crowley, W.F.; Ojeda, S.R.; Plant, T.M. Increased hypothalamic GPR54 signalling: a potential mechanism for initiation of puberty in primates. Proc. Natl. Acad. Sci. USA, 2005, 102, 2129-2134. (Pubitemid 40262023)
54. Morgan, K.; Millar, R.P. Evolution of GnRH ligand precursors and GnRH receptors in protochordate and vertebrate species. Gen. Comp. Endocrinol., 2004, 139, 191-197. (Pubitemid 39550345)
55. Strader, C.D.; Fong, T.M.; Tota, M.R.; Underwood, D. Structure and function of G-protein coupled receptors. Ann. Rev. Biochem., 1994, 63, 101-132. (Pubitemid 24218630)
56. Heding, A.; Vrecl, M.; Hanyaloglu, A.C.; Sellar, R.; Taylor, P.L.; Eidne, K.A. The rat gonadotropin-releasing hormone receptor internalizes via a beta-arrestin-independent, but dynamin-dependent, pathway: addition of a carboxyl-terminal tail confers beta-arrestin dependency. Endocrinology, 2000, 141, 299-306. (Pubitemid 32260371)
57. Ferguson, S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signalling. Pharmacol. Rev., 2001, 53, 1-24. (Pubitemid 32173106)
58. Pawson, A.J.; Morgan, K.; Maudsley, S.R.; Millar, R.P. Type II Gonadotropin-releasing hormone (GnRHII) in reproductive biology. Reproduction, 2003, 126, 271-278. (Pubitemid 37185227)
59. Davidson, J.S.; Wakefield, I.K.; Millar, R.P. Absence of rapid desensitization of the mouse gonadotropin-releasing hormone receptor. Biochem. J., 1994, 300, 299-302. (Pubitemid 24167881)
60. Kakar, S.S.; Jennes, L. Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues. Cancer Lett., 1995, 98, 57-62.
61. Bull, P.; Morales, P.; Huyser, C.; Socias, T.; Castellon, E.A. Expression of GnRH receptor in mouse and rat testicular germ cells. Mol. Hum. Reprod., 2000, 6, 582-586.
62. Grundker, C.; Gunthert, A.R.; Westphalen, S.; Emons, G. Biology of the gonadotropin-releasing hormone system in gynaecological cancers. Eur. J. Endocrinol., 2002, 146, 1-14. (Pubitemid 34126412)
63. Gault, P.M.; Maudsley, S.; Lincoln, G.A. Evidence that gonadotropin-releasing hormone II is not a physiological regulator of gonadotropin secretion in mammals. J. Neurendocrinol., 2003, 15, 831-839. (Pubitemid 37038608)
64. Terasawa, E. Gonadotropin-releasing hormone-II: is this neuropeptide important for mammalian reproduction? Endocrinology, 2003, 144, 3-4. (Pubitemid 36076085)
65. Haisenleder, D.J.; Yasin, M.; Dalkin, A.C.; Gilrain, C.; Marshall, J.C. GnRH regulates steroidogenic factor 1 (SF-1) gene expression in rat pituitary. Endocrinology, 1996, 137, 5719-5722.
66. Halvorson, L.M. Transcriptional regulation of the LH beta gene by gonadotropin releasing hormone and the protein kinase C system. Vitam. Horm., 2000, 60, 195-227.
67. Harrison, G.S.; Wierman, M.E.; Nett, T.M.; Glode, L.M. Gonadotropinreleasing hormone and its receptor in normal and malignant cells. Endocr.- related Cancer, 2004, 11, 725-748. (Pubitemid 40065547)
68. Ruf, F.; Fink, M.Y.; Sealfon, S.C. Structure of the GnRH receptor-stimulated signaling network: insights from genomics. Front. Neuroendocrinol., 2003, 24, 181-199. (Pubitemid 37329471)
69. Kraus, S.; Levy, G.; Hanoch, T.; Naor, Z.; Seger, R. Gonadotropin- releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways. Cancer Res., 2004, 64, 5736-5744. (Pubitemid 39095572)
70. McArdle, C.A.; Franklin, J.; Green, L.; Hislop; J.N. Signalling, cycling and desensitisation of gonadotropin releasing hormone receptors. J. Endocrinol., 2002, 173, 1-11.
71. Zhang, J.; Ferguson, S.S.; Barak, L.S.; Aber, M.J.; Giros, B.; Lefkowitz, R.J.; Caron, M.G. Molecular mechanisms of G protein-coupled receptor signalling: role of G protein-coupled receptor kinases and arrestins in receptor desensitisation and resensitization. Receptor. Channels, 1997, 5, 193-199. (Pubitemid 28242957)
72. Miller, W.E.; Lefkowitz, R.J. Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signalling and trafficking. Curr. Opin. Cell Biol., 2001, 13, 139-145. (Pubitemid 32209213)
73. Ellis L.M.; Fidler, I.J. Angiogenesis and breast cancer metastasis. Lancet, 1995, 346, 388-390.
74. Folkman J. Clinical application of research on angiogenesis. N. Engl. J. Med., 1995, 333, 1757-1763.
75. Schneider, B.P.; Miller, K.D. Angiogenesis of breast cancer. J. Clin. Oncol., 2005, 23, 1782-1790. (Pubitemid 46211430)
76. Longatto Filho, A.; Lopes, J.M.; Schmitt, F.C. Angiogenesis and breast cancer. J. Oncol., 2010, doi: 10.1155/2010/576384
77. Heinmann, R.; Ferguson, D.; Gray, S.; Hellman, S. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res. Tr., 1998, 52, 147-158. (Pubitemid 29056092)
78. Algire, G.H.; Chalkley, F.Y.; Legallais, F.Y.; Park, H.D. Vascular reactions to normal and malignant tissue in vivo. Vascular reactions of mice to wound and to normal and neoplastic transplants. J. Natl. Cancer Inst., 1945, 6, 7385.
79. Marinho, A.; Soares, R.; Ferro, J.; Lacerda, M.; Schmitt, F.C. Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Pathol. Res. Pract., 1997, 193(4), 267-273. (Pubitemid 27399700)
80. Guidi, A.J.; Fischer, L.; Harris, J.R.; Schnitt, S.J. Microvessel density and distribution in ductal carcinoma in situ of the breast. J. Natl. Cancer Inst., 1994, 86, 614-619. (Pubitemid 24143171)
81. Guinebretiere, J.M.; Le Monique, G.; Gavoile A.; Bahi J.; Contesso G. Angiogenesis and risk of breast cancer in women with fibrocystic disease. J. Natl. Cancer Inst., 1994, 86, 635-636.
82. Folkman J. Tumor angiogenesis: therapeutic implications. New Engl. J. Med., 1971, 285, 1182-1186.
83. Weidner, N.; Folkman, J.; Pozza F.; Bevilacqua, P.; Alfred, E.N.; Moore, D.H.; Meli, S.; Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J. Natl. Cancer Inst., 1992, 84, 1875-1887. (Pubitemid 23004615)
84. Weidner, N.; Semple, J.P.; Welch, W.R.; Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl. J. Med., 1991, 324(1), 1-8.
85. Duarte, M.; Filho Longatto, A.; Schmitt, F.C. Angiogenesis, haemostasis and cancer: new paradigms and old concerns. J. Brasil. Patol. Med. Laborat., 2007, 43(6), 441-449.
86. Nakamura, Y.; Yasuoka, H.; Tsujimoto, M; Yang, Q.; Imabun, S.; Nakahara, M.; Nakao, K.; Nakamura, M.; Mori, I.; Kakudo, K. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Clin. Canc. Res., 2003, 19(14), 5313-5317. (Pubitemid 37413585)
87. Shi H.; Harris, A.L. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J. Mammary Gland Biol., 2006, 11, 41-52. (Pubitemid 44309188)
88. Shibuya, M. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. J. Biochem. Mol. Biol., 2008, 41(4), 278-286. (Pubitemid 351656921)
89. Hayes, D.F.; Miller, K.; Sledge, G. Angiogenesis as targeted breast cancer therapy. The Breast, 2007, 16, S17-S19.
90. Di Domenico, M.; Ricciardi, C.; Fusco, A.; Pierantoni, G.M. Anti-VEGF therapy in breast and lung mouse models of cancers. J. Biomed. Biotechnol., 2011, doi: 10.1155/2011/947928.
91. Bos, R.; Zhong, H.; Hanrahan, C.F.; Mommers,E.C.; Semenza, G.L.; Pinedo, H.M.; Abeloff, M.D.; Simons, J.W.; van Diest P.J.; van der Wall, E. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J. Natl. Cancer Inst., 2001, 93, 309-314.
92. Pradeep, C.R.; Sunila, E.S.; Kuttan, G. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies. Integr. Cancer Ther., 2005, 4(4), 315-321. (Pubitemid 41698180)
93. Smith, N.R.; Baker, D.; James, N.H.; Ratcliffe, K.; Jenkins, M.; Ashton, S.E.; Sproat, G.; Schwann, R.; Gray, N.; Ryan, A.; Jugernsmeier, J.M. Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers. Clin. Cancer Res., 2010, 16(14), 3548-3561.
94. Shalaby, F.; Rossant, J.; Yamaguchi, T.P., Gertsenstein, M.; Wu, X.F.; Breitman, M.L.; Schuh, A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature, 1995, 376, 62-66.
95. Yang, S.; Toy, K.; Ingle, G.; Zlot, C.; Williams, P.M.; Fuh, G.; Li, B.; de Vos, A.; Gerritsen, M.E. Vascular endothelial growth factor-induced genes inhuman umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors. Arterioscl. Thromb. Vasc. Biol., 2002, 22, 1797-1803. (Pubitemid 35315764)
96. Goodsell, D.S. The molecular perspective: VEGF and angiogenesis. The Oncologist, 2002, 7, 569-570. (Pubitemid 36009004)
97. Mumprecht, V.; Detmar, M. Lymphangiogenesis and cancer metastasis. J. Cell. Mol. Med., 2009, 13(8), 1405-1416.
98. Wulfing, P.; Kersting, C.; Tio J.; Sonntag, B.; Buerger, H.; Wulfing, C.; Euler, U.; Boecker, W.; Tulusan, A.H.; Kiesel, L. Expression of endothelin- A receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer. Br. J. Cancer, 2004, 91(3), 434-440. (Pubitemid 39093560)
99. Zhou, D.; Cheng, S.Q.; Ji, H.F.; Wang, G.S.; Xu, H.T.; Zhang, G.Q.; Pang, D. Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer. J. Canc. Res. Clin. Oncol., 2010, 136(11), 1719-1727.
100. Tsutsui, S.; Inoue, H.; Yasuda, K.; Suzuki, K.; Takeuchi, H.; Nishizaki, T.; Higashi, H.; Era, S.; Mori, M. Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and micro vessel density. Breast Canc. Res. Treat., 2006, 98(3), 261-266. (Pubitemid 44195595)
101. Min, Y.; Ren, X.; Vaught, D.B; Chen, J.; Donnelly, E.; Lynch, C.C.; Lin, P.C. Tie-2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer. Canc Res., 2010, 70(7), 2819-2828.
102. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature, 2008, 454(7203), 436-444.
103. Valkovic, T.; Dobrila, F.; Melato M.; Sasso F.; Rizzardi, C.; Jonjic, N. Correlation between vascular endothelial growth factor, angiogenesis and tumour associated macrophages in invasive ductal breast carcinoma. Virchows Archiv., 2002, 440(6), 583-588. (Pubitemid 34809688)
104. Pavlakis, K.; Messini, I.; Vrekoussis, T.; Yiannou, P.; keramopoullos, D.; Louvrou, N.; Loiakakos, T.; Stathopoulos, E.N. The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions. BMC Cancer, 2008, 8, 88.
105. Oka, N.; Soeda, A.; Inagaki, A., Onodera, M.; Maruyama, H.; Hara, A.; Kunisada, T.; Mori, H.; Iwama, T. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells. Biochem. Biophys. Res. Commun., 2007, 360(3), 553-559. (Pubitemid 47048135)
106. Takahashi, Y.; Yamaoka, K.; Nishikawa, M.; Takakura, Y. Quantitative and temporal analysis of gene silencing in tumour cells induced by small interfering RNA or short Hairpin RNA expressed from plasmid vectors. J. Pharmacol. Sci., 2009, 98(1), 74-80.
107. Perez Alenza, M.D.; Pena, L.; del Castillo N., Nieto, I. Factors influencing the incidence and prognosis of canine mammary tumours. J. Small Anim. Pract., 2000, 41, 287-291.
108. Theilen, G.H.; Madewell B.R. (Eds) Tumours of the mammary gland. In: Veterinary Cancer Medicine, 2nd edn. Lea & Febiger, Philadelphia, 1987, pp 327-344.
109. Karayannoupoulou, M.; Kaldrimidou, E.; Dessiris, A. Some epidemiological aspects of canine mammry tumors. Treatment and prognosis. Bull. Hellenic Vet. Med. Soc., 1989, 40, 111-121.
110. Rutteman, G.R. Hormones and mammary tumour disease in the female dog. An update. In vivo, 1990, 4, 33-40. (Pubitemid 20180058)
111. Yamagami, T.; Kobayashi, T.; Takahashi, K.; Sugiyama, M. Prognosis for canine malignant mammary tumors based on TNM and histologic classification. J. Vet. Med. Sci., 1996, 58, 1079-1083. (Pubitemid 126478412)
112. Morris, J.S.; Dobson, J.M.; Bostock, D.E.; O'Farrell, E. Effect of ovariohysterectomy in bitches with mammary neoplasms. Vet. Rec., 1998, 142, 656-658. (Pubitemid 128494522)
113. Donnay, Y.; Rauis, J.; Devleeschower, N.; Wouters-Ballman, P.; Leclerq, G.; Verstegen, J. Comparison of estrogen and progesterone receptor expression in normal and mammary tissues from dogs. Am. J. Vet. Res., 1995, 56, 1188-1194.
114. Millanta, F.; Calandrella, M.; Bari, G.; Niccolini, M.; Iannozzi, I.; Poli, A. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Res. Vet. Sci., 2005, 79(3), 225-232. (Pubitemid 41070360)
115. Tamada, H.; Kawate, N.; Inaba, T.; Sawada, T. Long term prevention of oestrus in the bitch and queen using chlormadinone acetate. Can. Vet. J., 2003, 44, 416-417. (Pubitemid 36747960)
116. Okada, H.; Nishijima, Y.; Yoshino, T.; Grone, A.; Capen, C.C.; Rosol, T.J. Immunohistochemical localization of parathyroid hormone related protein in canine mammary tumours. Vet. Pathol., 1997, 34, 356-359. (Pubitemid 127471120)
117. Donnay, I.; Devleeschower, N.; Wouters-Ballman, P.; Leclerq, G.; Verstegen, J. Relationship between receptors for epidermal growth factor and steroid hormones in normal, dysplastic and neoplastic canine mammary tissues. Res. Vet. Sci., 1996, 60, 251-254. (Pubitemid 126501605)
118. Millanta, F.; Silvestri, G.; Vaselli, C.; Citi, S.; Pisani, G.; Lorenzi, D.; Poli, A. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops. Res. Vet. Sci., 2006, 81, 350-357. (Pubitemid 44296251)
119. Hobson, B.; Denekamp, J. Endothelial cell proliferation in tumours and normal tissues: continuous labeling studies. Br. J. Canc., 1984, 49, 405-413. (Pubitemid 14125248)
120. Griffey, S.M.; Verstraete, F.J.; Kraegel, S.A.; Lucroy, M.D.; Madewell B.R. Computer-assisted image analysis of intratumoral microvessel density in mammary tumours from dogs. Am. J. Vet. Res., 1998, 59, 1238-1242. (Pubitemid 128472062)
121. Graham, J.C.; Myers, R.K. The prognostic significance of angiogenesis in canine mammry tumours. J. Vet. Int. Med., 1999, 13, 416-418.
122. Restucci, B.; Papparella, S.; Maiolino, P.; De Vico, G. Expression of vascular endothelial growth factor in canine mammary tumours. Vet. Pathol., 2002, 39, 488-493.
123. Millanta, F.; Lazzeri, G.; Vannozzi, I.; Vacava, P.; Poli, A. Correlation of vascular endothelial growth factor expression to overall survival (OS) in feline invasive mammary carcinomas. Vet. Pathol., 2002, 39, 690-696.
124. Kato, Y.; Asano K.; Mogi, T.; Kutara K.; Teshima, K.; Edamura, K.; Tsumagari, S.; Hasegawa, A.; Tanaka, S. Clinical significance of circulating vascular endothelial growth factor in dogs with mammary gland tumors. J. Vet. Med. Sci., 2007, 69(1), 77-80. (Pubitemid 46219466)
125. Millanta, F.; Caneschi, V.; Ressel, L.; Citi, S.; Poli, A. Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma. J. Comp. Path., 2010, 142, 36-42.
126. Al-Dissi, A.; Haines, D.M; Singh, B.; Kidney, B.A. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in canine simple mammary gland adenocarcinomas. Can. Vet. J., 2010, 51, 1109-1114.
127. Aten, F.R.; Ireland, J.J.; Weems, C.W.; Behrman, H.R. Presence of gonadotropin-releasing hormone-like proteins in bovine ovine ovaries. Endocrinology, 1987, 120, 1727-1733. (Pubitemid 17069198)
128. Ireland, J.J.; Aten, R.F.; Behrman, H.R. GnRH-like proteins in cows: concentrations during corpora lutea development and selective localization in granulosal cells. Biol. Reprod., 1988, 38, 544-550.
129. Oikawa, M.; Dargan, C.; Ny, T.; Hsueh, A.J. Expression of gonadotropin-releasing hormone and prothymosin-alpha messenger ribonucleic acid in the ovary. Endocrinology, 1990, 127, 2350-2356. (Pubitemid 20381768)
130. Rizzo, A.; Cosola, C.; Mutinati, M.; Spedicato, M.; Minoia, G.; Sciorsci, R.L. Bovine ovarian follicular cysts: in vitro effects of lecirelin, a GnRH analogue. Theriogenology, 2010, 7, 1559-1569.
131. Singh, R.; Graves, M.L.; Roskelley, C.D.; Giritharan, G.; Rajamahendran, R. Gonadotropin releasing hormone receptor gene and protein expression and immunohistochemical localization in bovine uterus and oviducts. Domest. Anim. Endocrinol., 2008, 34(3), 319-326. (Pubitemid 351335212)
132. Dong, K.W.; Marcelin, K.; Hsu, M.; Chiang, C.M.; Hoffman, G.; Roberts, J.L. Expression of gonadotropin-releasing hormone (GnRH) gene in human uterine endometrial tissue. Mol. Hum. Reprod., 1998, 4, 893-898. (Pubitemid 28430654)
133. Cheng, K.Y.; Nathwani, P.S.; Leung, P.C.K. Regulation of human gonadotropin-releasing hormone receptor gene expression in placental cells. Endocrinology, 2000, 141, 2340-2349. (Pubitemid 32269052)
134. Lefebvre, F.A.; Reeves, J.J.; Seguin, C.; Massicotte, J.; Labrie, F. Specific binding of a potent LHRH agonist in rat testis. Mol. Cell. Endocrinol., 1980, 20, 127-134.
135. Sharpe, R.M.; Fraser, H.M. The role of LH in regulation of Leydig cell responsiveness to an LHRH agonist. Mol. Cell. Endocrinol., 1983, 33, 131-146. (Pubitemid 14216045)
136. Botte, M.C.; Chamagne, A.M.; Carre, M.C.; Counis, R.; Kottler, M.L. Fetal expression of GnRH and GnRH receptors genes in rat testis and ovary. J. Endocrinol., 1998, 159, 179-189.
137. Chatzaki, E.; Bax, C.M.; Eidne, K.A.; Anderson, L.; Grudzinskas, J.G.; Gallagher, C.J. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor. Cancer Res., 1996, 56, 2059-2065. (Pubitemid 26119908)
138. Tieva, A.; Stattin, P.; Wikstrom, P.; Bergh, A.; Damber, J.E. Gonadotropin-releasing hormone receptor expression in the human prostate. Prostate, 2001, 47, 276-284.
139. Eidne, K.A.; Flanagan, C.A.; Millar, R.P. Gonadotropin-releasing hormone binding sites in human breast carcinoma. Science, 1985, 229, 989-993.
140. Moriya, T.; Suzuki, T.; Pilichowska, M.; Ariga, N.; Kimura, N.; Ouchi, N.; Nagura, H.; Sasano, H. Immuno-histochemical expression of gonadotropin-releasing hormone receptor in human breast carcinoma. Pathol. Int., 2001, 51, 333-337. (Pubitemid 32589020)
141. Qayum, A.; Gullik, W.; Clayton, R.C.; Sikora, K.; Waxman, J. The effects of gonadotropin-releasing hormone analogues in prostate cancer are mediated through specific tumour receptors. Br. J. Cancer, 1990, 62, 96-99. (Pubitemid 20226453)
142. Limonta, P.; Moretti, R.M.; Montagnani Marelli, M.; Dondi, D.; Parenti, M.; Motta, M. The luteinizing hormone-releasing hormone receptor in prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway. Endocrinology, 1999, 140, 5250-5256.
143. Emons, G.; Ortmann, O.; Becker, M.; Irmer, G.; Springer, B.; Laun, R.; Holzel, F.; Schulz, K.D.; Schally, A.V. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer lines. Cancer Res., 1993, 53, 5439-5446. (Pubitemid 23342164)
144. Emons, G.; Weiss, S.; Ortmann, O.; Grundker, C.; Schulz, K.D. LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer. Eur. J. Endocrinol., 2000, 142, 665-670.
145. Khan, K.N.; Kitajima, M.; Hiraki, K.; Fujishita, A.; Sekine, I.; Ishimaru, T.; Masuzaki, H. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum. Reprod., 2010, 25(3), 642-653.
146. Straub, B.; Muller, M.; Krause, H.; Schrader, M.; Goessl, C.; Heicappell, R., Miller, K. Increased incidence of luteinizing-hormone releasing hormone receptor gene messenger RNA expression in hormone-refractory human prostate cancers. Clin. Cancer Res., 2001, 7, 2340-2343.
147. Grundker, C.; Schlotawa, L.; Viereck, V.; Eicke, N.; Horst, A.; Kairies, B.; Emons, G. Antiproliferative effects of the GnRH antagonist cetrorelix and of
148. Sharma, R.; Hamilton, A.; Beith, J. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal woman. Cochrane Database Syst. Rev., 2008, 4, CD004562.
149. Tesone, M.; Bilotas, M.; Baranao, R.I.; Meresman, G. The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis. Gynecol. Obstet. Invest., 2008, 66, 10-18.
150. Kang, S.K.; Choi, K.C.; Yang, H.S.; Leung, P.C. Potential role of gonadotropin-releasing hormone (GnRH-I) and GnRH-II in the ovary and ovarian cancer. Endocr. Related Cancer, 2003, 10, 169-177. (Pubitemid 36758646)
151. Limonta, P.; Moretti, R.M.; Montagnani Morelli, M.; Motta, M. The biology of gonadotropin hormone-releasing hormone: role in the control of tumour growth and suppression. Front. Neuroendocrinol., 2003, 24, 279-295. (Pubitemid 38064319)
152. Montagnani Marelli, M.; Moretti, R.M.; Januszkiewicz-Caulier, J.; Motta, M.; Limonta, P. Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients? Curr. Cancer Drug Targets, 2006, 6, 257-269.
153. Volker, P.; Grundker, C.; Schmidt, O.; Schulz, K.D.; Emons, G. Expression of receptors for luteinizing-hormone releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing-hormone releasing hormone analogues. Am. J. Obstet. Gynecol., 2002, 186, 171-179. (Pubitemid 34165428)
154. Arencibia, J.M.; Schally, A.V. Luteinizing-hormone releasing hormone as an autocrine growth factor in ES-2 ovarian cancer cell line. Int. J. Oncol., 2000, 16, 1009-1013.
155. Miles, L.E.; Hanyaloglu, A.C., Dromey, J.R.; Pfleger, K.D.; Eidne, K.A. Gonadotropin-releasing hormone receptor-mediated growth suppression of immortalized Lbeta T2 gonadotrope and stable HEK293 cell lines. Endocrinology, 2004, 145, 194-204. (Pubitemid 38094516)
156. Limonta, P.; Dondi, D.; Moretti, R.M.; Maggi, R.; Motta, M. Antiproliferative effects of luteinizing-hormone releasing hormone agonists on the human prostatic cancer cell line LNCaP. J. Clin. Endocrinol. Metab., 1992, 75, 207-212.
157. Montagnani Marelli, M.; Moretti, R.M.; Dondi, D.; Limonta, P.; Motta, M. Effects of LHRH agonists on the growth of human protatic tumor cells: "in vitro" and "in vivo" studies. Arch. Ital. urol. Androl., 1997, 69, 257-263. (Pubitemid 27473951)
158. Dondi, D.; Festuccia, C.; Piccolella, M.; Bologna, M.; Motta, M. GnRH agonists and antagonist decreases the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system. Oncol. Rep., 2006, 15, 393-400.
159. Cheung, L.; Wong, A. Gonadotropin-releasing hormone: GnRH receptor signalling in extrapituitary tissues. FEBS J., 2008, 275, 5479-5495.
160. Yates, C.; Wells, A.; Turner, T. Luteinising-hormone releasing hormone analogues reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. Br. J. Cancer, 2005, 92, 366-375. (Pubitemid 40343154)
161. Enomoto, M.; Utsumi, M.; Park, M.K. Gonadotropin-releasing hormone induces actin cytoskeleton remodelling and affects cell migration in a cell-type- specific manner in TSU-Prl and DU-145 cells. Endocrinology, 2006, 147, 530-542. (Pubitemid 43004309)
162. Moretti, R.M.; Montagnani Marelli, M.; Van Groeninghen, J.C.; Limonta, P. Locally expressed LHRH receptors mediate the oncostatic and antimetastatic activity of LHRH agonists on melanoma cells. J. Clin. Endocrinol. Metab., 2002, 87, 3791-3797. (Pubitemid 34879529)
163. Folkman, J. Tumour angiogenesis: what is the evidence that tumours are angiogenesis-dependent? J. Natl. Cancer Inst., 1990, 82, 4-6. (Pubitemid 20020880)
164. Yoshiji, H.; Gomez, D.E.; Shibuya, M.; Thorgeirson, U.P. Expression of endothelial growth factor, its receptor and other angiogenic factors in human breast cancer. Cancer Res., 1996, 56, 2013-2016.
165. Parborell, F.; Irusta, G.; Celìn, R.; Tesone, M. Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs. Mol. Reprod. Develop., 2008, 75, 623-631. (Pubitemid 351323772)
166. Kupker, W.; Schultze-Mosgau, A.; Diedrick, K. Paracrine changes in the peritoneal environment of women wit endometriosis. Hum. Reprod. Update, 1998, 4, 719-723.
167. Meresman, G.F.; Bilotas, M.A.; Lombardi, E.; Tesone, M.; Sueldo, C.; Barañao, R.I. Effect of GnRH analogues on apoptosis and release of interleukin-1beta and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum. Reprod., 2003, 18(9), 1767-71. (Pubitemid 37107546)
168. Abulafia, O.; Kleinhaus, K.; Levi, G.; Lee, Y-C.; Sherer, D.M. Effect of gonadotropin-releasing hormone agonist treatment upon angiogenesis in uterine leiomyoma. Gynecol. Obstet. Invest., 2001, 52, 108-113. (Pubitemid 34701598)
169. Rutgers, J.L.; Spong, C.Y.; Sinow, R.; Heiner, J. Leupride acetate treatment and myoma arterial size. Obstet. Gynecol., 1995, 86, 386-388.
170. Gokdeniz, R.; Ozenb, U.S.; Mizrakb, B.; Bazoglua, N. GnRH agonist decreases endothelial nitric oxide synthase (eNOS) expression in leiomyoma. Int. J. Gynecol. Obstet., 2000, 70(3), 347-352.
171. Bergqvist, A.; Bruse, C.; Carlberg, M.; Carlstrom, K. Interleukin 1β, interleukin 6, and tumor-necrosis factor alpha in endometriotic tissue and in endometrium. Fertil. Steril., 2001, 75, 489-495. (Pubitemid 32175661)
172. McLaren, J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum. Reprod. Update, 2000, 6, 45-55. (Pubitemid 30099342)
173. Flores, A.I.; Bedoya, F.; Grau, M.; de Salamanca, R.E.; Vegh, I. In vivo effect of a luteinizing hormone-releaing hormone analog on vascular endothelial growth factor and epidermal growth factor receptor expression in mammary tumors. J. Carcinogenesis, 2009, 8, 11.
174. Moretti, R.M.; Mai, S.; Montagnani Marelli, M.; Bani, M.R.; Ghilardi, C.; Giavazzi, R.; Taylor, D.M.; Martini, P.G.V.; Limonta, P. Dual targeting of tumor and endothelial cells by gonadotropin-releasing hormone agonists to reduce melanoma angiogenesis. Endocrinology, 2010, 151, 4643-4653.
175. Van den Eynden, G.G.; Colpaert, C.G.; Couvelard, A. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph) angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology, 2007, 51 (4), 440-451. (Pubitemid 47437821)
176. Colpaert, C.G.; Vermeulen, P.B.; Fox, S.B.; Harris, A.L.; Dirix, L.Y.; Van Marck, E.A. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Breast Cancer Res. Treat., 2003, 81(2), 137-147. (Pubitemid 37211131)
177. Hasebe, T.; Sasaki, S.; Imoto, S.; Ochiai, A. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod. Pathol., 2001, 14, 325-337. (Pubitemid 32298918)
178. Kalluri, R.; Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer, 2006, 6, 392-401.
179. Feng, X.H.; Derynck, R. Specificity and versatility in TGF-beta signaling through Smads. Annu. Rev. Cell. Dev. Biol., 2005, 21, 659-693. (Pubitemid 41740650)
180. Massague, J.; Gomis, R.R. The logic of TGF-beta signaling. FEBS Lett., 2006, 580, 2811-2820.
181. Kingsley, D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev., 1994, 8(2), 133-8146.
182. Reiss, M. TGF-beta and cancer. Microbes Infect., 1999, 1, 1327-1347.
183. Massague, J. TGF-beta in cancer. Cell., 2008, 134, 215-230.
184. Roberts, A.B.; Wakefield, L.M. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. U S A., 2003, 100, 8621-8623. (Pubitemid 36899145)
185. Mahesh, V.B.; Dhandapani, K.M.; Brann, D.W. Role of astrocytes in reproduction and neuroprotection. Mol. Cell Endocrinol., 2006, 246 (1-2), 1-9. (Pubitemid 43238391)
186. Fister, S.; Günthert, A.R.; Aicher, B.; Paulini, K.W.; Emons, G.; Gründker, C. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax. Cancer Res., 2009, 69(16), 6473-6481.
187. Gordon, K.J.; Blobe, G.C. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim. Biophys. Acta., 2008, 1782, 197-228.